Latest On Eiger BioPharmaceuticals, Inc (EIGR):
About Eiger BioPharmaceuticals, Inc (EIGR):
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide for the treatment of congenital hyperinsulinism, as well as has completed Phase II clinical trials to treat post-bariatric hypoglycemia. The company was founded in 2008 and is headquartered in Palo Alto, California.
General
- Name Eiger BioPharmaceuticals, Inc
- Symbol EIGR
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 28
- Last Split Factor1:15
- Last Split Date2016-03-23
- Fiscal Year EndDecember
- IPO Date2014-01-30
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.eigerbio.com
Valuation
- Price/Book (Most Recent Quarter) 3.51
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.36
- Next Year EPS Estimate -$1.71
- Next Quarter EPS Estimate -$0.05
- Return on Assets -31%
- Return on Equity -86%
- Earnings Per Share -$3.65
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 316.98 million
- EBITDA -66959000
- Analyst Target Price $31.67
- Book Value Per Share $2.81
Share Statistics
- Shares Outstanding 33.9 million
- Shares Float 29.02 million
- % Held by Insiders 127%
- % Held by Institutions 74.5%
- Shares Short 1.55 million
- Shares Short Prior Month 1.58 million
- Short Ratio 6.55
- Short % of Float 5%
- Short % of Shares Outstanding 5%
Technicals
- Beta 1.41
- 52 Week High $13.99
- 52 Week Low $5.28
- 50 Day Moving Average 10.57
- 200 Day Moving Average 10.08
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Eiger BioPharmaceuticals, Inc (EIGR) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Eiger BioPharmaceuticals, Inc (EIGR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-03-09 | $N/A | -$0.57 | $0.38 | -249.45% |
2020-09-30 | 2020-11-05 | $N/A | -$0.52 | -$0.63 | 17.04% |
2020-06-30 | 2020-08-06 | $N/A | -$0.60 | -$0.73 | 18.02% |
2020-03-31 | 2020-05-07 | $N/A | -$0.62 | -$0.79 | 21.23% |
2019-12-31 | 2020-03-13 | $N/A | -$0.69 | -$0.80 | 14.07% |
2019-09-30 | 2019-11-07 | $N/A | -$0.76 | -$0.74 | -2.48% |
2019-06-30 | 2019-08-08 | $N/A | -$0.75 | -$0.74 | -1.53% |
2019-03-31 | 2019-05-09 | $N/A | -$0.90 | -$0.98 | 8.4% |
2018-12-31 | 2019-03-14 | $N/A | -$0.92 | -$0.82 | -11.65% |
2018-09-30 | 2018-11-09 | $N/A | -$1.20 | -$0.77 | -56.66% |
2018-06-30 | 2018-08-10 | $N/A | -$0.82 | -$0.85 | 2.96% |
2018-03-31 | 2018-05-11 | $N/A | -$0.84 | -$1.09 | 22.82% |
2017-12-31 | 2018-03-09 | $N/A | -$1.09 | -$1.05 | -3.61% |
2017-09-30 | 2017-11-09 | $N/A | -$1.10 | -$1.34 | 17.76% |
2017-06-30 | 2017-08-11 | $N/A | -$1.33 | -$1.31 | -1.72% |
2017-03-31 | 2017-05-12 | $N/A | -$1.34 | -$1.35 | 0.74% |
2016-12-31 | 2017-03-23 | $N/A | -$1.26 | -$1.38 | 8.91% |
2016-09-30 | 2016-11-08 | $N/A | -$1.49 | -$1.22 | -21.8% |
2016-06-30 | 2016-08-10 | $N/A | -$1.87 | -$1.10 | -70% |
2016-03-31 | 2016-05-16 | $N/A | -$10.42 | -$2.83 | -268.2% |
2015-09-30 | 2015-11-09 | $N/A | -$2.85 | -$3.30 | 13.64% |
2015-06-30 | 2015-08-11 | $N/A | -$8.40 | -$4.72 | -77.97% |
2015-03-31 | 2015-05-14 | $N/A | -$10.65 | -$6.78 | -57.08% |
2014-12-31 | 2015-03-31 | $N/A | -$7.50 | -$5.40 | -38.89% |
2014-09-30 | 2014-11-12 | $N/A | -$6.00 | -$5.64 | -6.38% |
2014-06-30 | 2014-08-07 | $N/A | -$5.70 | -$5.77 | 1.21% |
2014-03-31 | 2014-05-14 | $N/A | -$8.70 | -$9.00 | 3.33% |
2013-12-31 | 2014-03-31 | -$116.55 | -$7.05 | -1553.19% |
Eiger BioPharmaceuticals, Inc (EIGR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Eiger BioPharmaceuticals, Inc (EIGR) Chart:
Eiger BioPharmaceuticals, Inc (EIGR) News:
Below you will find a list of latest news for Eiger BioPharmaceuticals, Inc (EIGR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Eiger BioPharmaceuticals, Inc (EIGR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest EIGR Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 44 | $5.26 |
Jun 13, 2022 7:59 PM EST | 42 | $5.26 |
Jun 13, 2022 7:59 PM EST | 100 | $5.26 |
Jun 13, 2022 7:59 PM EST | 93 | $5.25 |
Jun 13, 2022 7:59 PM EST | 7 | $5.25 |
Eiger BioPharmaceuticals, Inc (EIGR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520171440/0001193125-20-171440-index.htm |
2019-12-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1305253/000000000019016767/0000000000-19-016767-index.htm |
2019-01-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000005341719000023/0000053417-19-000023-index.htm |
2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000083423720008122/0000834237-20-008122-index.htm |
2018-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000089924318027169/0000899243-18-027169-index.htm |
2018-10-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000090266418003855/0000902664-18-003855-index.htm |
2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000090266420000957/0000902664-20-000957-index.htm |
2019-06-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000091957419004168/0000919574-19-004168-index.htm |
2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000091957420001123/0000919574-20-001123-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000093583619000126/0000935836-19-000126-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000093583620000145/0000935836-20-000145-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000110465919008745/0001104659-19-008745-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000110465920021903/0001104659-20-021903-index.htm |
2019-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000113777419000043/0001137774-19-000043-index.htm |
2018-10-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000114420418055387/0001144204-18-055387-index.htm |
2018-10-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000114420418055388/0001144204-18-055388-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000117891319000438/0001178913-19-000438-index.htm |
2018-06-11 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1305253/000119312518189594/0001193125-18-189594-index.htm |
2018-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312518193255/0001193125-18-193255-index.htm |
2018-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312518247356/0001193125-18-247356-index.htm |
2018-08-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312518250675/0001193125-18-250675-index.htm |
2018-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312518304210/0001193125-18-304210-index.htm |
2018-10-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1305253/000119312518304289/0001193125-18-304289-index.htm |
2018-10-23 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1305253/000119312518305424/0001193125-18-305424-index.htm |
2018-10-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312518305472/0001193125-18-305472-index.htm |
2018-10-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1305253/000119312518305844/0001193125-18-305844-index.htm |
2018-11-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312518322746/0001193125-18-322746-index.htm |
2018-11-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312518323748/0001193125-18-323748-index.htm |
2018-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312518341240/0001193125-18-341240-index.htm |
2018-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312518353484/0001193125-18-353484-index.htm |
2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519003763/0001193125-19-003763-index.htm |
2019-01-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1305253/000119312519020636/0001193125-19-020636-index.htm |
2019-02-06 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1305253/000119312519029536/0001193125-19-029536-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1305253/000119312519039523/0001193125-19-039523-index.htm |
2019-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519069306/0001193125-19-069306-index.htm |
2019-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519074779/0001193125-19-074779-index.htm |
2019-03-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1305253/000119312519074970/0001193125-19-074970-index.htm |
2019-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519106558/0001193125-19-106558-index.htm |
2019-04-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1305253/000119312519109081/0001193125-19-109081-index.htm |
2019-04-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1305253/000119312519110948/0001193125-19-110948-index.htm |
2019-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519113453/0001193125-19-113453-index.htm |
2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1305253/000119312519122466/0001193125-19-122466-index.htm |
2019-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1305253/000119312519122480/0001193125-19-122480-index.htm |
2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519142983/0001193125-19-142983-index.htm |
2019-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519150558/0001193125-19-150558-index.htm |
2019-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519171309/0001193125-19-171309-index.htm |
2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519216853/0001193125-19-216853-index.htm |
2019-08-08 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519217043/0001193125-19-217043-index.htm |
2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519287307/0001193125-19-287307-index.htm |
2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312519315318/0001193125-19-315318-index.htm |
2019-12-20 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1305253/000119312519321040/0001193125-19-321040-index.htm |
2019-12-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1305253/000119312519323545/0001193125-19-323545-index.htm |
2020-01-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520001790/0001193125-20-001790-index.htm |
2020-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520002612/0001193125-20-002612-index.htm |
2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520072305/0001193125-20-072305-index.htm |
2020-03-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1305253/000119312520072874/0001193125-20-072874-index.htm |
2020-03-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520081589/0001193125-20-081589-index.htm |
2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1305253/000119312520123158/0001193125-20-123158-index.htm |
2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1305253/000119312520123187/0001193125-20-123187-index.htm |
2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520136236/0001193125-20-136236-index.htm |
2020-05-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520146138/0001193125-20-146138-index.htm |
2020-05-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1305253/000119312520155782/0001193125-20-155782-index.htm |
2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520171440/0001193125-20-171440-index.htm |
2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520211938/0001193125-20-211938-index.htm |
2020-08-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1305253/000119312520212104/0001193125-20-212104-index.htm |
2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520269865/0001193125-20-269865-index.htm |
2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000119312520286830/0001193125-20-286830-index.htm |
2018-11-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919118060179/0001209191-18-060179-index.htm |
2018-11-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919118060345/0001209191-18-060345-index.htm |
2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919118061728/0001209191-18-061728-index.htm |
2018-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919118063781/0001209191-18-063781-index.htm |
2018-12-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919118064161/0001209191-18-064161-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119002201/0001209191-19-002201-index.htm |
2019-01-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119003030/0001209191-19-003030-index.htm |
2019-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119003038/0001209191-19-003038-index.htm |
2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119007882/0001209191-19-007882-index.htm |
2019-03-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021276/0001209191-19-021276-index.htm |
2019-03-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021277/0001209191-19-021277-index.htm |
2019-03-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021279/0001209191-19-021279-index.htm |
2019-03-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021280/0001209191-19-021280-index.htm |
2019-03-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021281/0001209191-19-021281-index.htm |
2019-03-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021282/0001209191-19-021282-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021283/0001209191-19-021283-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021284/0001209191-19-021284-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021285/0001209191-19-021285-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021286/0001209191-19-021286-index.htm |
2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119025562/0001209191-19-025562-index.htm |
2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119025563/0001209191-19-025563-index.htm |
2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119025564/0001209191-19-025564-index.htm |
2019-04-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119025623/0001209191-19-025623-index.htm |
2019-04-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119026233/0001209191-19-026233-index.htm |
2019-05-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119033497/0001209191-19-033497-index.htm |
2019-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119033500/0001209191-19-033500-index.htm |
2019-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119048804/0001209191-19-048804-index.htm |
2019-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119048805/0001209191-19-048805-index.htm |
2019-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919119048817/0001209191-19-048817-index.htm |
2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120003153/0001209191-20-003153-index.htm |
2020-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120005548/0001209191-20-005548-index.htm |
2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120005872/0001209191-20-005872-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018973/0001209191-20-018973-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018977/0001209191-20-018977-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018979/0001209191-20-018979-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018984/0001209191-20-018984-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018988/0001209191-20-018988-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018991/0001209191-20-018991-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018995/0001209191-20-018995-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120019001/0001209191-20-019001-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120019003/0001209191-20-019003-index.htm |
2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120019004/0001209191-20-019004-index.htm |
2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120019682/0001209191-20-019682-index.htm |
2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120019685/0001209191-20-019685-index.htm |
2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1305253/000120919120046449/0001209191-20-046449-index.htm |
2019-11-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1305253/000121390019023939/0001213900-19-023939-index.htm |
2018-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1305253/000156459018021197/0001564590-18-021197-index.htm |
2018-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1305253/000156459018028934/0001564590-18-028934-index.htm |
2019-03-14 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1305253/000156459019007830/0001564590-19-007830-index.htm |
2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1305253/000156459019018009/0001564590-19-018009-index.htm |
2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1305253/000156459019030837/0001564590-19-030837-index.htm |
2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1305253/000156459019041773/0001564590-19-041773-index.htm |
2020-03-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1305253/000156459020010645/0001564590-20-010645-index.htm |
2020-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1305253/000156459020014794/0001564590-20-014794-index.htm |
2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1305253/000156459020022884/0001564590-20-022884-index.htm |
2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1305253/000156459020037833/0001564590-20-037833-index.htm |
2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1305253/000156459020051341/0001564590-20-051341-index.htm |
2019-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1305253/000161577419002505/0001615774-19-002505-index.htm |
2019-12-31 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1305253/999999999520000006/9999999995-20-000006-index.htm |
2018-08-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1305253/999999999718007372/9999999997-18-007372-index.htm |
2018-12-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1305253/999999999718009617/9999999997-18-009617-index.htm |
Eiger BioPharmaceuticals, Inc (EIGR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eiger BioPharmaceuticals, Inc (EIGR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 127%Institutional Ownership: 7450%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-12-20 | Thomas John Dietz | Director | Buy | 5,000.00 | 9.98 | 49,900.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919118063781/0001209191-18-063781-index.htm |
2018-09-05 | James P Shaffer | Chief Business Officer | Buy | 1,500.00 | 7.95 | 11,921.25 | 11,421.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021285/0001209191-19-021285-index.htm |
2019-04-22 | Sriram Ryali | Chief Financial Officer | Buy | 1,250.00 | 11.08 | 13,852.75 | 1,250.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119025564/0001209191-19-025564-index.htm |
2019-03-05 | James P Shaffer | Chief Business Officer | Buy | 1,500.00 | 7.95 | 11,921.25 | 12,921.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021285/0001209191-19-021285-index.htm |
2018-10-18 | PARTNERS X LP INTERWEST | 10% Share Holder | Sell | 26,465.00 | 12.00 | 317,606.47 | 1,362,327.00 | https://www.sec.gov/Archives/edgar/data/1305253/000089924318027169/0000899243-18-027169-index.htm |
2018-10-18 | PARTNERS X LP INTERWEST | 10% Share Holder | Sell | 210,800.00 | 12.07 | 2,544,714.36 | 1,388,792.00 | https://www.sec.gov/Archives/edgar/data/1305253/000089924318027169/0000899243-18-027169-index.htm |
2019-09-05 | Sriram Ryali | Chief Financial Officer | Buy | 149.00 | 9.37 | 1,395.68 | 1,399.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119048805/0001209191-19-048805-index.htm |
2019-09-05 | James P Shaffer | Chief Business Officer | Buy | 1,500.00 | 7.95 | 11,921.25 | 14,421.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119048817/0001209191-19-048817-index.htm |
2018-11-27 | Eldon C. III Mayer | Director | Buy | 7,500.00 | 9.92 | 74,407.50 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919118060179/0001209191-18-060179-index.htm |
2019-04-22 | Thomas John Dietz | Director | Buy | 5,000.00 | 11.05 | 55,250.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119025563/0001209191-19-025563-index.htm |
2020-03-05 | James P Shaffer | Chief Business Officer | Buy | 1,500.00 | 7.31 | 10,965.00 | 15,921.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120019004/0001209191-20-019004-index.htm |
2020-03-05 | Sriram Ryali | Chief Financial Officer | Buy | 229.00 | 7.31 | 1,673.99 | 1,628.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120019001/0001209191-20-019001-index.htm |
2019-04-23 | Thomas John Dietz | Director | Buy | 5,000.00 | 11.10 | 55,495.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119025623/0001209191-19-025623-index.htm |
2001-11-28 | Eldon C. III Mayer | Director | Buy | 6,000.00 | 10.07 | 60,447.00 | 21,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919118060179/0001209191-18-060179-index.htm |
2020-01-10 | Thomas John Dietz | Director | Buy | 4,000.00 | 13.94 | 55,760.00 | 24,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120003153/0001209191-20-003153-index.htm |
2018-11-29 | Eldon C. III Mayer | Director | Buy | 4,000.00 | 10.21 | 40,840.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919118060345/0001209191-18-060345-index.htm |
2020-03-12 | Thomas John Dietz | Director | Buy | 5,000.00 | 29,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018977/0001209191-20-018977-index.htm | ||
2020-01-24 | Eldon C. III Mayer | Ex VP & Chief Commerc. Officer | Buy | 5,000.00 | 13.52 | 67,602.50 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120005548/0001209191-20-005548-index.htm |
2020-03-16 | Thomas John Dietz | Director | Buy | 1,000.00 | 4.95 | 4,950.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120019685/0001209191-20-019685-index.htm |
2020-03-12 | Jeffrey S Glenn | Director | Buy | 5,000.00 | 36,355.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018984/0001209191-20-018984-index.htm | ||
2020-01-31 | Eldon C. III Mayer | Ex VP & Chief Commerc. Officer | Buy | 7,500.00 | 37,500.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120005872/0001209191-20-005872-index.htm | ||
2019-04-22 | Stephana Eilene Patton | Officer | Buy | 1,000.00 | 11.03 | 11,030.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119025562/0001209191-19-025562-index.htm |
2020-03-05 | Stephana Eilene Patton | Officer | Buy | 820.00 | 7.31 | 5,994.20 | 4,820.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018995/0001209191-20-018995-index.htm |
2020-08-12 | Jeffrey S Glenn | Director | Buy | 500.00 | 11.28 | 5,637.50 | 500.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120046449/0001209191-20-046449-index.htm |
2020-03-12 | Amit Sachdev | Director | Buy | 5,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120019003/0001209191-20-019003-index.htm | ||
2020-03-12 | Christine Murray | Director | Buy | 5,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018991/0001209191-20-018991-index.htm | ||
2020-03-12 | David Apelian | Director | Buy | 5,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018973/0001209191-20-018973-index.htm | ||
2020-03-12 | Evan Loh | Director | Buy | 5,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018988/0001209191-20-018988-index.htm | ||
2020-08-12 | Jeffrey S Glenn | Director | Buy | 4,500.00 | 11.44 | 51,465.15 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120046449/0001209191-20-046449-index.htm |
2018-12-06 | Thomas John Dietz | Director | Buy | 5,000.00 | 11.26 | 56,300.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919118061728/0001209191-18-061728-index.htm |
2019-02-04 | David A Cory | President and CEO | Buy | 227.00 | 14.13 | 3,207.51 | 58,678.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119007882/0001209191-19-007882-index.htm |
2017-03-06 | David A Cory | President and CEO | Buy | 1,325.00 | 8.20 | 10,868.31 | 60,003.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021284/0001209191-19-021284-index.htm |
2017-09-05 | David A Cory | President and CEO | Buy | 1,500.00 | 9.90 | 14,853.75 | 61,503.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021284/0001209191-19-021284-index.htm |
2018-03-05 | David A Cory | President and CEO | Buy | 1,500.00 | 8.03 | 12,048.75 | 63,003.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021284/0001209191-19-021284-index.htm |
2018-09-05 | David A Cory | President and CEO | Buy | 1,500.00 | 7.95 | 11,921.25 | 64,503.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021284/0001209191-19-021284-index.htm |
2019-03-05 | David A Cory | President and CEO | Buy | 1,500.00 | 7.95 | 11,921.25 | 66,003.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021284/0001209191-19-021284-index.htm |
2019-02-04 | David A Cory | President and CEO | Buy | 343.00 | 11.26 | 3,862.18 | 66,346.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119026233/0001209191-19-026233-index.htm |
2020-03-16 | Jeffrey S Glenn | Director | Buy | 30,000.00 | 5.03 | 150,813.00 | 66,355.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120019682/0001209191-20-019682-index.htm |
2019-09-05 | David A Cory | President and CEO | Buy | 1,500.00 | 7.95 | 11,921.25 | 67,846.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119048804/0001209191-19-048804-index.htm |
2017-03-06 | James P Shaffer | Chief Business Officer | Buy | 1,301.00 | 8.20 | 10,671.45 | 6,921.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021285/0001209191-19-021285-index.htm |
2020-03-05 | David A Cory | President and CEO | Buy | 1,500.00 | 7.31 | 10,965.00 | 69,346.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120018979/0001209191-20-018979-index.htm |
2020-08-11 | Jeffrey S Glenn | Director | Buy | 5,000.00 | 11.49 | 57,463.50 | 71,355.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919120046449/0001209191-20-046449-index.htm |
2018-11-26 | Eldon C. III Mayer | Director | Buy | 7,500.00 | 9.75 | 73,143.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919118060179/0001209191-18-060179-index.htm |
2017-09-05 | James P Shaffer | Chief Business Officer | Buy | 1,500.00 | 9.90 | 14,853.75 | 8,421.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021285/0001209191-19-021285-index.htm |
2018-03-05 | James P Shaffer | Chief Business Officer | Buy | 1,500.00 | 8.03 | 12,048.75 | 9,921.00 | https://www.sec.gov/Archives/edgar/data/1305253/000120919119021285/0001209191-19-021285-index.htm |